Package 71335-2566-3

{"route": ["ORAL"], "spl_id": "20567a71-8bfc-47d2-922b-4ff642aba801", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["65d13d0e-cf7f-4422-81f1-3dfce4722718"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71335-2566-0)", "package_ndc": "71335-2566-0", "marketing_start_date": "20250205"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE (71335-2566-1)", "package_ndc": "71335-2566-1", "marketing_start_date": "20250205"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (71335-2566-2)", "package_ndc": "71335-2566-2", "marketing_start_date": "20250205"}, {"sample": false, "description": "4 TABLET in 1 BOTTLE (71335-2566-3)", "package_ndc": "71335-2566-3", "marketing_start_date": "20250205"}, {"sample": false, "description": "7 TABLET in 1 BOTTLE (71335-2566-4)", "package_ndc": "71335-2566-4", "marketing_start_date": "20250205"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (71335-2566-5)", "package_ndc": "71335-2566-5", "marketing_start_date": "20250205"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-2566-6)", "package_ndc": "71335-2566-6", "marketing_start_date": "20250205"}, {"sample": false, "description": "8 TABLET in 1 BOTTLE (71335-2566-7)", "package_ndc": "71335-2566-7", "marketing_start_date": "20250205"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71335-2566-8)", "package_ndc": "71335-2566-8", "marketing_start_date": "20250205"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (71335-2566-9)", "package_ndc": "71335-2566-9", "marketing_start_date": "20250205"}], "brand_name": "Valacyclovir", "product_id": "71335-2566_20567a71-8bfc-47d2-922b-4ff642aba801", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "71335-2566", "generic_name": "Valacyclovir", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20230214", "listing_expiration_date": "20261231"}